THROUGH
TECHNOLOGY, SCIENCE AND COLLABORATION
For Patients and their Families
Here you will find useful information about clinic, our doctors, booking an appointment…
For Health Professionals
Find out useful information about our doctors, case studies….
Associate Professor Andrew Chang, Dr Thomas Pham, Dr Ran Wan and Dr Thomas Hong will be heading to Cambodia in August 2019 to help restore vision to underprivileged patients.
Read more
New technologies are being utilised in the operating theater.
Read more
Associate Professor Andrew Chang Recently presented at the Global Retinal Network Program on new developments in retinal research and the multi-disciplinary approach in treating patients with retinal disease.
Read moreDo you have dry
age-related macular degeneration? You may be eligible to participate in one of our clinical trials. Please contact our research team for more information.
Announces dosing of first patient in OTX-TKI phase 1 clinical trial for the treatment of wet age-related macular degeneration (AMD).
Read more
An orange a day keeps the macular degeneration away.
http://www.abc.net.au/news/2018-07-18/oranges-may-reduce-macular-degeneration-risk/10002722
Read more
-
Scientific Journal Publications
Publications
Read more2018 Spooner K, Mhlanga C, Hong T, Broadhead GK, Chang A, The Burden of neovacsular age-related macular degeneration:
-
Abstracts
Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.
Read moreActa Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Broadhead GK 1 , Hong T, Chang AA.
-
Abstracts
Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.
Read moreGraefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1217-25. doi: 10.1007/s00417-014-2799-8. Epub 2014 Sep 10. Zhu M 1 , Chew
